Related references
Note: Only part of the references are listed.Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015
A. Khan et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
Fengxia Chen et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw
Reginald H. Goodday
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2015)
Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics
Tae Min You et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2015)
Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents
Giuseppina Campisi et al.
FUTURE ONCOLOGY (2014)
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials
Wei-Xiang Qi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update
Salvatore L. Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2014)
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2013)
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Allan Lipton et al.
EUROPEAN JOURNAL OF CANCER (2012)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Osteonecrosis of the Jaw in a Patient on Denosumab
Tara L. Aghaloo et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2010)
Share Paper
